Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

Fluoropyrimidines are widely used in the treatment of several types of solid tumors. Although most often well tolerated, severe toxicity is encountered in ~ 20–30% of the patients. Individualized dosing for these patients can reduce the incidence of severe fluoropyrimidine‐related toxicity. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Knikman, Jonathan E., Gelderblom, Hans, Beijnen, Jos H., Cats, Annemieke, Guchelaar, Henk‐Jan, Henricks, Linda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983939/
https://www.ncbi.nlm.nih.gov/pubmed/33020924
http://dx.doi.org/10.1002/cpt.2069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983939/
https://www.ncbi.nlm.nih.gov/pubmed/33020924
http://dx.doi.org/10.1002/cpt.2069

Ejemplares similares